Prognostic impact of high p16/cyclin D1 index in breast cancer

被引：1
|
作者：
Kim, Gi Jeong [1 ,2 ]
Kim, Dong-Hoon [3 ]
Min, Kyueng-Whan [4 ]
Kim, Se Hoon [5 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Dept Pathol, Coll Med, Incheon, South Korea
[2] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, 29 Saemunanro, Seoul 03181, South Korea
[4] Hanyang Univ, Guri Hosp, Dept Pathol, Coll Med, Guri, Gyeonggi Do, South Korea
[5] Yonsei Univ, Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2019年 / 12卷 / 06期
关键词：
Breast cancer; p16; cyclin D1; index; prognosis; CYCLIN D1; RETINOBLASTOMA PROTEIN; P16; PROTEINS; EXPRESSION; OVEREXPRESSION; CARCINOMA; METHYLATION; RB; PROGRESSION; P16(INK4A);
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Proteins p16 and cyclin D1 (CCND1) are known to tightly regulate the G1/S transition during the cell cycle, but their role in breast cancer development and progression is not clear. We investigated 224 cases of breast cancer from the Kangbuk Samsung Medical Center between 2000-2005. Expression levels of p16 and CCND1 were assessed by tissue microarray-based immunohistochemistry. A p16/CCND1 index was divided into low- and high-expression groups using receiver operating characteristic curves. The p16/CCND1 index was significantly different across molecular subtypes and a high p16/CCND1 index was statistically correlated with survival rates. This p16/CCND1 index may be an indicator of poor patient outcome and thus, represents a potential therapeutic target.
引用
收藏
页码：2224 / 2232
页数：9
相关论文
共 50 条
  • [21] Cyclin D1 gene amplification is highly homogeneous in breast cancer
    Burandt, Eike
    Gruenert, Martin
    Lebeau, Annette
    Choschzick, Matthias
    Quaas, Alexander
    Jaenicke, Fritz
    Mueller, Volkmar
    Scholz, Ursula
    Bokemeyer, Carsten
    Petersen, Cordula
    Geist, Stefan
    Paluchowski, Peter
    Wilke, Christian
    Heilenkoetter, Uwe
    Simon, Ronald
    Sauter, Guido
    Wilczak, Waldemar
    BREAST CANCER, 2016, 23 (01) : 111 - 119
  • [22] The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis
    Ren, Baoming
    Li, Wenjun
    Yang, Yanping
    Wu, Songdi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [23] The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer
    Kucukzeybek, Betul Bolat
    Bayoglu, Ibrahim Vedat
    Kucukzeybek, Yuksel
    Alacacioglu, Ahmet
    Yigit, Seyran
    Sari, Aysegul Akder
    Akyol, Murat
    Tarhan, Mustafa Oktay
    JOURNAL OF BUON, 2017, 22 (04): : 947 - 952
  • [24] Analysis of the cyclin D1/p16/pRb pathway in parathyroid adenomas
    Eva Cristóbal
    Begoña Arribas
    Juan Tardío
    José A. Alcázar
    Juan C. Martínez-Montero
    Rafael Carrión
    José R. Polo
    Laura Gil
    Marta Azañedo
    José M. Rojas
    Javier Menárguez
    Endocrine Pathology, 2000, 11 : 259 - 266
  • [25] Analysis of the cyclin D1/p16/pRb pathway in parathyroid adenomas
    Cristóbal, E
    Arribas, B
    Tardío, J
    Alcázar, JA
    Martínez-Montero, JC
    Carrión, R
    Polo, JR
    Gil, L
    Azañedo, M
    Rojas, JM
    Menárguez, J
    ENDOCRINE PATHOLOGY, 2000, 11 (03) : 259 - 266
  • [26] Cyclin D1, Retinoblastoma and p16 Protein Expression in Carcinoma of the Gallbladder
    Srivastava, Vineeta
    Patel, Brijesh
    Kumar, Mohan
    Shukla, Mridula
    Pandey, Manoj
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2711 - 2715
  • [27] Evaluation of Gastroenteropancreatic Neuroendocrine Tumors for Ki 67, p16 and Cyclin D1 Expression
    Ozyalvacli, Gulzade
    Pasaoglu, Esra
    Gucin, Zuhal
    Behzatoglu, Kemal
    Gunver, Feray
    Bozkurt, Erol Rustu
    ISTANBUL MEDICAL JOURNAL, 2011, 12 (03): : 105 - 112
  • [28] THE EXPRESSION OF p16 AND CYCLIN D1 IN PROLIFERATIVE ENDOMETRIUM AND ENDOMETRIAL CARCINOMA
    主改霞
    邢兰瑛
    吕海霞
    梁劲荃
    Journal of Pharmaceutical Analysis, 2000, (02) : 163 - 167
  • [29] Alterations in the RB, p16, and cyclin D1 cell cycle control pathway in osteosarcomas
    Belchis, DA
    Gocke, CD
    Geradts, J
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2000, 19 (05): : 377 - 389
  • [30] The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung
    Beasley, MB
    Lantuejoul, S
    Abbondanzo, S
    Chu, WS
    Hasleton, P
    Travis, WD
    Brambilla, E
    HUMAN PATHOLOGY, 2003, 34 (02) : 136 - 142
12345